132 related articles for article (PubMed ID: 37814871)
1. [Heterogeneity analysis of pancreatic cancer and identification of molecular subtypes of tumor cells based on CEACAM5, LGALS1 and CENPF gene expression].
Sun J; Lu P; Guan S; Liu S
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Sep; 43(9):1567-1576. PubMed ID: 37814871
[TBL] [Abstract][Full Text] [Related]
2. Identification of CEACAM5 as a stemness-related inhibitory immune checkpoint in pancreatic cancer.
Shi H; Tsang Y; Yang Y
BMC Cancer; 2022 Dec; 22(1):1291. PubMed ID: 36494785
[TBL] [Abstract][Full Text] [Related]
3. Cartilage Oligomeric Matrix Protein, COMP may be a Better Prognostic Marker Than CEACAM5 and Correlates With Colon Cancer Molecular Subtypes, Tumor Aggressiveness and Overall Survival.
Wusterbarth E; Chen Y; Jecius H; Krall E; Runyan RB; Pandey R; Nfonsam V
J Surg Res; 2022 Feb; 270():169-177. PubMed ID: 34687957
[TBL] [Abstract][Full Text] [Related]
4. FBW7 suppresses metastasis of colorectal cancer by inhibiting HIF1α/CEACAM5 functional axis.
Li Q; Li Y; Li J; Ma Y; Dai W; Mo S; Xu Y; Li X; Cai S
Int J Biol Sci; 2018; 14(7):726-735. PubMed ID: 29910683
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
Zhao L; Zhao H; Yan H
BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
[TBL] [Abstract][Full Text] [Related]
6. RNA sequencing reveals the transcriptomic landscape and alternative splicing events induced by LGALS1 silencing in non-small cell lung cancer.
Shi H; Zhang Y; Liu J; Wang Y; Fang P
Adv Clin Exp Med; 2024 Jan; 33(1):79-90. PubMed ID: 37341175
[TBL] [Abstract][Full Text] [Related]
7. CEACAM5 inhibits the lymphatic metastasis of head and neck squamous cell carcinoma by regulating epithelial-mesenchymal transition via inhibiting MDM2.
Wang X; Li Y; Pan M; Lu T; Wang M; Wang Z; Liu C; Hu G
Clin Sci (Lond); 2022 Nov; 136(22):1691-1710. PubMed ID: 36377775
[TBL] [Abstract][Full Text] [Related]
8. CEACAM5 stimulates the progression of non-small-cell lung cancer by promoting cell proliferation and migration.
Zhang X; Han X; Zuo P; Zhang X; Xu H
J Int Med Res; 2020 Sep; 48(9):300060520959478. PubMed ID: 32993395
[TBL] [Abstract][Full Text] [Related]
9. Novel protein isoforms of carcinoembryonic antigen are secreted from pancreatic, gastric and colorectal cancer cells.
Hatakeyama K; Wakabayashi-Nakao K; Ohshima K; Sakura N; Yamaguchi K; Mochizuki T
BMC Res Notes; 2013 Sep; 6():381. PubMed ID: 24070190
[TBL] [Abstract][Full Text] [Related]
10. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
11. Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer.
DeLucia DC; Cardillo TM; Ang L; Labrecque MP; Zhang A; Hopkins JE; De Sarkar N; Coleman I; da Costa RMG; Corey E; True LD; Haffner MC; Schweizer MT; Morrissey C; Nelson PS; Lee JK
Clin Cancer Res; 2021 Feb; 27(3):759-774. PubMed ID: 33199493
[TBL] [Abstract][Full Text] [Related]
12. Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.
Pan S; Chen R; Tamura Y; Crispin DA; Lai LA; May DH; McIntosh MW; Goodlett DR; Brentnall TA
J Proteome Res; 2014 Mar; 13(3):1293-306. PubMed ID: 24471499
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer survival analysis defines a signature that predicts outcome.
Raman P; Maddipati R; Lim KH; Tozeren A
PLoS One; 2018; 13(8):e0201751. PubMed ID: 30092011
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
Front Immunol; 2021; 12():648917. PubMed ID: 33777046
[No Abstract] [Full Text] [Related]
15. Genomic analysis of pancreatic cancer reveals 3 molecular subtypes with different clinical outcomes.
Hwang JW; Jang SK; Lee DJ
Medicine (Baltimore); 2021 Apr; 100(14):e24969. PubMed ID: 33832071
[TBL] [Abstract][Full Text] [Related]
16. KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate unfavorable prognosis of breast cancer patients.
Wang XM; Zhang Z; Pan LH; Cao XC; Xiao C
Breast Cancer Res Treat; 2019 Apr; 174(2):375-385. PubMed ID: 30535933
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of morphologic subtypes of pancreatic ductal adenocarcinoma using surgical and EUS-FNB specimens.
Rasmussen LG; Verbeke CS; Sørensen MD; Pfeiffer P; Tan Q; Mortensen MB; Fristrup C; Detlefsen S
Pancreatology; 2021 Apr; 21(3):530-543. PubMed ID: 33637450
[TBL] [Abstract][Full Text] [Related]
18. Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progression of pancreatic cancer.
Chen H; Wang X; Wu F; Mo X; Hu C; Wang M; Xu H; Yao C; Xia H; Lan L
Genomics; 2021 Jan; 113(1 Pt 2):1087-1095. PubMed ID: 33166601
[TBL] [Abstract][Full Text] [Related]
19. Immunogenomic analysis reveals LGALS1 contributes to the immune heterogeneity and immunosuppression in glioma.
Chen Q; Han B; Meng X; Duan C; Yang C; Wu Z; Magafurov D; Zhao S; Safin S; Jiang C; Cai J
Int J Cancer; 2019 Jul; 145(2):517-530. PubMed ID: 30613962
[TBL] [Abstract][Full Text] [Related]
20. The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes.
Basturk O; Tan M; Bhanot U; Allen P; Adsay V; Scott SN; Shah R; Berger MF; Askan G; Dikoglu E; Jobanputra V; Wrzeszczynski KO; Sigel C; Iacobuzio-Donahue C; Klimstra DS
Mod Pathol; 2016 Sep; 29(9):1058-69. PubMed ID: 27282351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]